| Type of financial instrument | Financial instrument | ISIN code | Nature of transaction | Linked to a share option programme | Volume | Unit | Price per unit | Currency code | Transaction date | Trading venue |
|---|---|---|---|---|---|---|---|---|---|---|
| Share | Hansa Biopharma AB | SE0002148817 | Acquisition | 290 | Quantity | 216.60 | SEK | 11/02/2019 | NASDAQ STOCKHOLM AB - NORDIC@MID | |
| Share | Hansa Biopharma AB | SE0002148817 | Acquisition | 30 | Quantity | 181.70 | SEK | 29/04/2019 | NASDAQ STOCKHOLM AB - NORDIC@MID | |
| Share | Hansa Biopharma AB | SE0002148817 | Acquisition | 40 | Quantity | 181.90 | SEK | 29/04/2019 | NASDAQ STOCKHOLM AB - NORDIC@MID |
| Financial instrument | ISIN code | Nature of transaction | Transaction date | Trading venue | Volume | Weighted average price |
|---|---|---|---|---|---|---|
| Hansa Biopharma AB | SE0002148817 | Acquisition | 11/02/2019 | NASDAQ STOCKHOLM AB - NORDIC@MID | 290 (Quantity) | 216.60 SEK |
| Hansa Biopharma AB | SE0002148817 | Acquisition | 29/04/2019 | NASDAQ STOCKHOLM AB - NORDIC@MID | 70 (Quantity) | 181.81428571 SEK |
| Total: | 360 |